The recombinant Lettuce infectious yellows virus minor capsid protein (recombinant LIYV minor capsid protein) is a genetically engineered form of the minor capsid protein (CPm) found in the Lettuce infectious yellows virus (LIYV), a member of the genus Crinivirus. This protein plays a crucial role in the transmission of LIYV by its vector, the whitefly Bemisia tabaci. The recombinant version of this protein is used in research to study its functions and interactions with the whitefly vector.
The minor capsid protein (CPm) of LIYV is essential for the retention and transmission of the virus by whiteflies. Studies have shown that when recombinant LIYV capsid components, including CPm, are fed to whitefly vectors, significantly more whiteflies retain the recombinant CPm compared to other capsid proteins . This retention occurs primarily in the anterior foregut or cibarium of the whitefly, which is crucial for virus transmission .
Retention Assays: Experiments using bacterial-expressed recombinant LIYV capsid proteins demonstrated that a significant number of whiteflies that fed on recombinant CPm showed fluorescent signals in their foreguts, indicating successful retention .
Transmission Studies: A transmission-defective CPm mutant was unable to be retained or transmitted by whiteflies, while restoring the CPm function restored both retention and transmission capabilities .
Chimeric mutants of LIYV CPm were engineered by incorporating sequences from another crinivirus, lettuce chlorosis virus (LCV). These mutants, such as CPmP-1, CPmP-2, CPmP-3, and CPmP-4, contained varying percentages of LCV CPm amino acids. All these mutants were capable of systemic movement in plants and formed virus particles, but their transmission efficiency was not detailed in the available literature .
While the full-length LIYV-encoded CPm is dispensable for systemic plant movement, it is crucial for whitefly transmission. Mutants lacking a complete CPm can still move systemically within plants but fail to be transmitted by whiteflies .
Characteristics | Description |
---|---|
Role in Transmission | Essential for virion retention and transmission by whiteflies. |
Retention Location | Anterior foregut or cibarium of the whitefly. |
Systemic Movement | Dispensable for systemic plant movement. |
Transmission Requirement | Required for whitefly transmission. |
Mutant | LCV CPm Amino Acid Content | Systemic Movement | Transmission |
---|---|---|---|
CPmP-1 | 60% (positions 3 to 294) | Yes | Not detailed |
CPmP-2 | 46% (positions 3 to 208) | Yes | Not detailed |
CPmP-3 | 51% (positions 3 to 238) | Yes | Not detailed |
CPmP-4 | 41% (positions 261 to 442) | Yes | Not detailed |
Minor capsid protein that encapsidates the 5'-terminal portion of the viral genome.
KEGG: vg:991078
LIYV possesses bipolar filamentous particles with a distinctive structural organization. The virion consists of four primary structural proteins: the major coat protein (CP), minor coat protein (CPm), heat shock protein 70 homolog (HSP70h), and a 59-kDa protein (P59). The main "body" of the virion is predominantly composed of CP subunits, while the "head" region is formed by the assembly of CPm subunits .
Immunogold labeling and transmission electron microscopy (IGL-TEM) analyses have confirmed this polar morphology, with CPm specifically localized to one end of the virion. This structural configuration is similar to other members of the Closteroviridae family . The structural organization appears critical for virion stability and biological function, particularly for vector transmission.
While CP constitutes the majority of the virion capsid, CPm plays a vital role in the encapsidation of the 5' end of the viral RNA genome. Research with related viruses like Citrus tristeza virus (CTV) and Beet yellows virus (BYV) indicates that CPm, along with HSP70h and P59/P61/P64, encapsidates approximately 630-650 nucleotides at the 5' end of the genomic RNA .
Production of recombinant LIYV CPm typically involves molecular cloning of the CPm open reading frame (ORF) into appropriate expression vectors. The CPm gene can be amplified from LIYV-infected plant tissue using reverse transcription-polymerase chain reaction (RT-PCR). For instance, primers targeting nucleotide positions 4847 to 5909 of LIYV RNA 2 can be used to amplify the complete CPm ORF .
The expression system chosen depends on the experimental objectives. Bacterial expression systems (typically E. coli) are commonly used for biochemical and structural studies, while plant-based expression systems may be preferred for functional analyses. For bacterial expression, the CPm gene is typically cloned into vectors containing a histidine tag or other affinity tag to facilitate purification.
Purification of recombinant CPm typically follows these methodological steps:
Induction of protein expression in the chosen expression system
Cell lysis under conditions that maintain protein solubility
Affinity chromatography using the expressed tag
Size exclusion chromatography to remove aggregates
Concentration and buffer exchange to prepare the protein for downstream applications
Verification of purity by SDS-PAGE and Western blotting using CPm-specific antibodies
For functional studies, it is crucial to assess the proper folding of recombinant CPm, which may require additional biophysical characterization.
The role of CPm in vector transmission can be studied through several complementary approaches:
In vitro acquisition and transmission assays: Purified LIYV virions or recombinant CPm can be fed to whitefly vectors (Bemisia tabaci biotype A) through membrane feeding systems. The whiteflies are then transferred to healthy host plants to assess transmission efficiency . This approach has revealed that virions are retained in the anterior foregut or cibarium of vector biotypes but not in non-vector biotypes .
Immunofluorescent localization: This technique involves feeding virions or recombinant capsid components to whiteflies, followed by feeding antibodies specific to these components. Fluorescent signals can then be detected in specific regions of the insect's digestive tract, providing visual evidence of binding and retention .
Infectivity neutralization assays: Purified virions are pre-incubated with antibodies against specific capsid components before being fed to whiteflies. If the antibodies block transmission, this suggests that the targeted protein is involved in vector interaction. Studies have shown that anti-CPm antibodies effectively neutralize LIYV transmission, while antibodies against CP do not .
Mutagenesis studies: Specific mutations can be introduced into the CPm gene to identify regions critical for vector transmission. For example, the p1-5b mutant, which contains a frameshift mutation resulting in a truncated CPm, formed virions that could systemically infect plants but could not be transmitted by whiteflies .
The table below summarizes the relationship between CPm integrity and whitefly transmission:
LIYV Variant | CPm Status | Systemic Plant Infection | Whitefly Transmission |
---|---|---|---|
Wild-type | Full-length | Yes | Yes |
p1-5b mutant | Truncated (<50%) | Yes | No |
pR6-5b | Truncated (<50%) | Yes | No |
pR6-5bM1 (restoration) | Full-length | Yes | Yes |
The relationship between CPm mutations and their effects on virion assembly and vector transmission represents a critical area of research. Studies have demonstrated that certain mutations in the CPm gene can significantly impact viral biology without preventing systemic infection.
Western blot analyses of purified p1-5b virions failed to detect either the complete CPm or the truncated form, suggesting that the truncated protein is either not incorporated into virions or lacks immunogenicity . Interestingly, immunocapture/RT-PCR analysis indicated that both the 5' and 3' ends of LIYV RNAs 1 and 2 are present in virions derived from the CPm truncation mutant, suggesting that RNA protection is maintained despite the absence of detectable CPm .
When the mutation was corrected in an engineered restoration mutant (p1-5bM1), both systemic plant infection and whitefly transmission were restored, confirming that the full-length CPm is specifically required for vector transmission but dispensable for systemic movement within plants .
These findings indicate several possible mechanisms:
The truncated CPm may still be incorporated into virions but lack epitopes recognized by antibodies
Other capsid proteins (CP, HSP70h, or P59) may compensate for CPm function in encapsidation
The full-length CPm may contain specific domains that interact with receptors in the whitefly foregut
The molecular basis of the interaction between LIYV CPm and whitefly vector components remains an active area of investigation. Research suggests that the retention of LIYV virions in the anterior foregut or cibarium of the whitefly vector is mediated by specific interactions between CPm and putative receptors in these regions .
Immunofluorescence studies have demonstrated that when recombinant LIYV capsid components (CP, CPm, HSP70h, and P59) were individually fed to whitefly vectors, significantly more whiteflies retained the recombinant CPm compared to other proteins . This selective retention of CPm correlates strongly with transmission capability.
The specificity of this interaction is further demonstrated by vector biotype specificity: fluorescent signals indicating virion retention were observed in the anterior foregut or cibarium of B. tabaci biotype A (a vector) but not in non-vector biotypes . This biotype specificity suggests that genetic differences between whitefly populations affect the presence or structure of the putative CPm receptors.
The nature of these receptors remains to be fully characterized, but they likely involve specific proteins or glycoproteins in the chitin lining of the foregut. The interaction appears to be relatively stable but reversible, consistent with the semi-persistent transmission mode of LIYV .
A hypothetical model for this interaction involves:
Initial attachment of virions to the foregut through CPm-receptor binding
Retention of virions during feeding and for a limited period afterward
Release of virions during subsequent feeding on a new host plant
Infection of phloem cells by the released virions
Future research directions include identifying and characterizing the specific whitefly receptor proteins and determining the precise binding domains within the LIYV CPm.
The structure-function relationship of LIYV CPm shows both similarities and differences compared to other members of the genus Crinivirus and the broader family Closteroviridae. Comparative analyses provide insights into conserved domains that may be critical for specific functions.
Like LIYV, other criniviruses possess a minor capsid protein that is localized to one end of the virion, creating a polar structure. This architectural feature appears to be conserved across the family Closteroviridae, including members of the genera Closterovirus (e.g., BYV) and Ampelovirus .
The table below summarizes comparative features of CPm across selected viruses in the family Closteroviridae:
Virus | Genus | CPm Size (kDa) | CPm Location | Role in Vector Transmission | Vector |
---|---|---|---|---|---|
LIYV | Crinivirus | ~50 | Virion head | Essential | B. tabaci biotype A |
CTV | Closterovirus | ~27 | Virion head | Essential | Aphids |
BYV | Closterovirus | ~24 | Virion head | Essential | Aphids |
BPYV | Crinivirus | ~53 | Virion head | Essential | Trialeurodes vaporariorum |
Despite these similarities, there are significant differences in the molecular weight and amino acid sequence of CPm proteins across different viruses, which likely reflect adaptations to different vector species. For instance, LIYV and other criniviruses are transmitted by whiteflies, while closteroviruses are typically transmitted by aphids .
Sequence analysis of CPm from different criniviruses reveals variable and conserved regions. The conserved regions may be involved in fundamental functions such as RNA binding or interactions with other capsid proteins, while variable regions may be involved in vector-specific interactions. Detailed structural studies of these proteins would significantly advance our understanding of their functional domains.
Working with recombinant LIYV CPm presents several experimental challenges that researchers must address:
Protein solubility and stability: CPm, like many viral capsid proteins, may have hydrophobic regions that can lead to aggregation and precipitation during expression and purification. To address this challenge:
Optimize expression conditions (temperature, induction time, media composition)
Consider fusion partners that enhance solubility (MBP, SUMO, thioredoxin)
Test different buffer compositions during purification
Use detergents or membrane mimetics if CPm has membrane-interacting domains
Proper folding: Ensuring that recombinant CPm maintains its native conformation is critical for functional studies. Approaches include:
Circular dichroism spectroscopy to assess secondary structure
Limited proteolysis to evaluate tertiary structure
Functional binding assays to verify activity
Co-expression with chaperones to assist folding
Yield optimization: Obtaining sufficient quantities of purified protein can be challenging. Strategies include:
Testing different expression systems (bacterial, insect cells, plant-based)
Optimizing codon usage for the expression host
Using strong, inducible promoters
Scaling up cultivation volume
Functional assessment: Confirming that recombinant CPm retains its biological activity requires appropriate assays:
In vitro binding assays with whitefly foregut extracts
Membrane feeding experiments with purified protein
Assembly assays with other viral components
In vitro RNA binding studies
Storage stability: Maintaining protein activity during storage is crucial. Considerations include:
Testing different buffer compositions and pH values
Adding stabilizing agents (glycerol, reducing agents)
Evaluating storage at different temperatures
Assessing freeze-thaw stability or considering lyophilization
By systematically addressing these challenges, researchers can develop robust protocols for producing and working with recombinant LIYV CPm, enabling more detailed studies of its structure and function.
The critical role of CPm in LIYV whitefly transmission makes it a promising target for developing virus-resistant crop varieties through various biotechnological approaches:
Transgenic expression of modified CPm: Plants can be engineered to express modified forms of CPm that interfere with the transmission cycle. Potential mechanisms include:
Competition with virus-derived CPm for vector binding sites
Expression of truncated CPm that disrupts virion assembly
Production of CPm with altered binding domains that interact with but do not support transmission
RNA interference (RNAi): Plants can be engineered to express double-stranded RNA (dsRNA) or hairpin RNA constructs targeting the CPm gene, leading to sequence-specific degradation of viral RNA:
Targeting conserved regions of the CPm gene may provide broader resistance
Using tissue-specific promoters active in phloem can focus resistance where the virus replicates
Stacking RNAi constructs targeting multiple viral genes (including CPm) may provide more durable resistance
CRISPR-Cas technologies: These can be employed to:
Modify host factors required for CPm function
Create viral traps that capture virions through CPm-specific binding
Engineer resistance by targeting conserved regions of the viral genome
Decoy molecules: Plants can be engineered to produce peptides or proteins that mimic the whitefly receptor for CPm:
These decoys would bind to CPm and prevent virion retention in the vector
Secretion of these molecules into phloem sap would allow them to be acquired by feeding whiteflies
This approach targets the transmission cycle without directly affecting the virus
The table below summarizes potential resistance strategies targeting LIYV CPm:
Strategy | Mechanism | Advantages | Challenges |
---|---|---|---|
Modified CPm expression | Competitive inhibition | Directly targets transmission | May require high expression levels |
CPm-targeting RNAi | RNA degradation | Well-established technology | Virus may evolve to escape |
CRISPR-Cas system | Multiple possible mechanisms | Precise targeting | Regulatory hurdles |
Decoy molecules | Binding interference | Novel approach | Requires receptor identification |
Experimental validation of these approaches would involve:
Molecular confirmation of the transgene or modification
Challenge experiments with viruliferous whiteflies
Assessment of virus accumulation and symptom development
Field trials under natural infection pressure